Abstract:Objective: To investigate the expression of fibroblast growth factor receptor 2 (FGFR2) in clear cell renal cell carcinoma (ccRCC; or kidney renal clear cell carcinoma, KIRC), to analyze the relationship between the expression of FGFR2 and the clinical pathological features and prognosis of ccRCC, to study the relationship between the expression of FGFR2 and other molecules, and to explore its role in the development of ccRCC. Methods: Gene expressional and clinical information of ccRCC patients were downloaded from The Cancer Genome Atlas (TCGA) and Gene Expression Omnibus(GEO) database. Next, the data were transformed and collated. In the study, 104 clinical ccRCC samples and corresponding paracancerous normal tissue samples were collected from Department of Urology, Peking University First Hospital. Immunohistochemistry (IHC) was performed and the staining results were scored, so as to compare the expression of FGFR2 in ccRCC and paracancerous normal tissues. Besides, quantify real-time polymerase chain reaction (qRT-PCR) was used to detect the mRNA expression level of FGFR2 in normal renal epithelial cell lines (293) and ccRCC cell lines (786-O, 769-P, OSRC-2, Caki-1, ACHN, and A498). In addition, the relationship between FGFR2 expression and clinical pathological characteristics (including TNM staging and pathological grading) and survival prognosis in ccRCC patients was further analyzed. Furthermore, the relationship between FGFR2 expression and B cells, T cells, natural killer (NK) cells and neutrophil infiltration in the ccRCC patients was analyzed, and the Biological General Repository for Interactionh Datasets (BioGRID) was used to builds protein-protein interaction (PPI) networks to study molecules that interacted with the FGFR2 protein. Results: In the TCGA database, the expression of FGFR2 was down-regulated in ccRCC tissue samples compared with normal tissue samples, and the expression in the GEO database also showed this differences. Furthermore, FGFR2 expression was downregulated in ccRCC clinical samples and ccRCC cell lines, compared with corresponding paracancerous normal tissue or normal renal epithelial cell lines. In addition, FGFR2 high expression was associated with earlier, lower-level ccRCC and was associated with a better prognosis in the patients with ccRCC. Moreover, FGFR2 expression was not significantly related to B cells, T cells, NK cells and neutrophil infiltration, and the PPI network showed that FGFR2 protein interacted with certain molecules. Conclusion: Our work sheds light on the potential role of FGFR2 in the development of ccRCC, suggesting that FGFR2 may serve as a prognostic marker and potential therapeutic target for patients with ccRCC.

Preliminary Study of the Relationship Between ABCG_2 and Renal Carcinoma Stem Cell

The combination of stem cell markers CD133 and ABCG2 predicts relapse in stage I non-small cell lung carcinomas

[Expression of ATP-binding Cassette Transporter ABCG2 in Gastric Carcinoma and Its Significance].

ABCG2: a Potential Marker of Stem Cells and Novel Target in Stem Cell and Cancer Therapy.

Expression of Potential Cancer Stem Cell Marker ABCG2 is Associated with Malignant Behaviors of Hepatocellular Carcinoma

Expression and Significance of ABCG2 in Transitional Cell Carcinoma of Bladder

Expression of glucose transporter-1 and -3 in the head and neck carcinoma--the correlation of the expression with the biological behaviors.

Expression of ATP-binding Cassette Superfamily G Member 2 and Β-Tubulin-ⅲ in Human Breast Carcinomas and Clinical Significance

Expressions of ABCG2 and CD44~+/CD24~- cells in breast carcinoma and their relationship with prognosis

Expression of ABCG2 in Human Liver Cancer Cell Lines and Its Related Functions

Systematic errors of EIT systems determined by easily-scalable resistive phantoms

The progress of ABCG2 in tumor of digestive system

Correlation of ABCG2 expression with the efficacy of irinotecan chemotherapy in colorectal cancer patients

Expression of the Stem Cell Marker ABCB5 in Normal and Tumor Tissues

Working Paper 6 on the National Health Service.

ABCG2/V-ATPase was associated with the drug resistance and tumor metastasis of esophageal squamous cancer cells

[Pilot Study on the Correlation Between High Incidence of CD44+/CD24 -/Low/abcg2- Cells and Poor Prognosis in Breast Cancer].

Influence of polymorphisms of ABCB1 and ABCC2 on mRNA and protein expression in normal and cancerous kidney cortex

ABCG2 Gene Expression in Non-Small Cell Lung Cancer

ABCG2 is Required for Self-Renewal and Chemoresistance of CD133-positive Human Colorectal Cancer Cells

[Expression and significance of fibroblast growth factor receptor 2 in clear cell renal cell carcinoma]